Gene Query: ANGEL1

Dataset Description Geneva Score
Cleavage Factor Im as a key regulator of 3’ UTR length 30.06
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 26.19
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 19.28
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 18.75
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 16.75
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 16.31
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 14.13
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 13.13
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 12.66
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 11.89
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 11.79
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 11.53
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 11.48
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 11.33
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 11.33
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 11.31
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 10.8
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 10.76
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 10.71
RNA expression following TMPRSS11B overexpression or depletion 10.26
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 10.26
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 10.21
Induced DNA demethylation, genome instability and transcription 10.0
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 10.0
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 9.82
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 9.8
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 9.65
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 9.46
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 9.44
MeRIP-seq for heat shock in B-cell lymphoma cells 9.35
Transcriptome analyses of human pancreatic islets and pseudoislets 9.32
Glioblastoma stem cells infected by ZIKA virus 9.18
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 8.72
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 8.72
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 8.59
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 8.39
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 8.35
Survival of pancreatic cancer cells lacking KRAS function 8.34
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 7.86
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 7.71
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 7.71
RNA-seq of YB5 cells treated with Proscillaridin A 7.59
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 7.5
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 7.46
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 7.42
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 7.38
RNA-seq analysis of uveal melanoma cells treated with FR900359 7.26
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 7.25
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 7.15
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 7.15
Statins modulate endothelial transcriptional profile by inhibiting EZH2 7.13
Paxillin regulates genomic networks in prostate cancer [LNCaP] 7.02
N6-methyladenine DNA Modification in Glioblastoma 6.96
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 6.96
The role of FAM46C in myeloma cells [sequencing] 6.92
The role of FAM46C in myeloma cells 6.92
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 6.89
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 6.89
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.84
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.84
The conserved transcriptional landscapes in human spermatogenesis 6.7
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.66
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.66
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 6.58
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 6.58
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 6.39
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 6.37
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 6.22
Genome wide expression change by RNF168 knocking down in MCF-7 cells 6.15
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 6.08
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 6.04
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 6.01
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 6.0
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 5.91
Trascriptome of thyroid cancer-induced macrophages 5.86
RNA-seq of tumor cells following angiopellosis extravasation 5.85
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 5.83
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 5.74
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 5.7
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 5.61
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 5.6
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 5.57
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 5.56
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 5.5
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.4
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 5.37
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 5.37
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 5.36
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 5.35
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 5.34
RNAseq Study in CC-671 Treated Cal-51 Cells 5.33
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 5.33
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 5.32
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 5.32
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 5.29
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 5.27
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 5.27
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 5.27
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 5.22
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 5.21
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 5.2
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 5.17
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 5.17
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 5.17
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 5.17
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 5.13
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 5.09
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 5.04
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.96
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.96
Identifying the molecular mode of action of itraconazole in colorectal cancer 4.96
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 4.95
Effect of BMP inhibition or stimulation of primary human keratinocytes 4.95
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 4.95
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 4.95
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 4.95
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 4.95
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 4.95
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 4.93
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 4.93
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 4.87
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 4.87
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 4.81
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.8
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 4.73
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 4.62
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 4.57
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 4.48
The transcriptome effect of overexpressing EZH2 in MCF7 4.47
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 4.45
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 4.43
NAPRT activation of macrophages 4.43
RNA splicing alteration on glioblastoma and normal neural stem cells 4.41
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 4.41
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 4.4
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 4.4
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 4.21
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 4.21
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 4.19
HEK293 TFAM Knockout Expression Study 4.12
Systematic discovery of endogenous human ribonucleoprotein complexes 4.11
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 4.1
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 4.1
H1609088 Human RNA-Sequencing 4.08
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 4.08
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.06
HNRNPM-regulated splicing dependencies in prostate cancer 4.03
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 4.03
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 4.02
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 3.99
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 3.99
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 3.99
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 3.99
Gene expression profile in breast cancer cell lines using RNA sequencing 3.94
Dtx3L and Androgen Signaling in Prostate Cancer 3.94
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 3.93
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 3.93
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 3.91
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 3.88
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 3.87
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 3.85
RNA-seq analysis and shRNA screen of breast cancer 3.83
RNA-seq analysis of breast cancer 3.83
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 3.83
Transciptomic profiling of human fetal lung samples 3.82
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 3.81
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 3.76
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 3.7
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 3.7
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 3.68
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.67
Novel Targeting of Transcription and Metabolism in Glioblastoma 3.66
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 3.63
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 3.63
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.61
Identification of Atrial Fibrillation associated genes and functional non-coding variants 3.59
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 3.59
RNA-seq analysis of differentiating human erythroblasts 3.55
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 3.55
RNA-sequencing of human liver tissue 3.53
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 3.52
snRNAs as regulators of alternative splicing 3.51
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 3.48
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 3.45
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 3.43
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 3.43
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 3.42
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 3.42
RNA-seq analyisis of PUM2 knockout cells 3.41
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 3.4
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 3.4
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 3.39
RNA-seq in transgenic cells 3.36
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 3.34
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 3.34
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 3.33
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 3.32
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 3.31
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 3.31
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 3.3
iPSC-Derived Cholangiocytes 3.3
Universal alternative splicing of noncoding exons 3.27
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 3.27
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 3.26
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 3.26
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 3.25
METTL3 and WTAP 3.22
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 3.22
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 3.21
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 3.17
SRSF2 mutations impair hematopoiesis and alter exon recognition 3.17
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 3.16
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.16
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.16
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 3.15
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 3.15
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 3.15
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 3.15
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 3.13
3’ Uridylation Expands miRNA Target Repertoire 3.13
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.11
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 3.1
Paxillin regulates genomic networks in prostate cancer [C4-2] 3.1
JAK dependent survival of ALK- ALCL 3.09
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 3.06
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 3.04
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 3.04
Transcriptome of activated human and mouse MAIT cells 3.04
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 2.99
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.99
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 2.99
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 2.98
RNA-seq analysis of control and Myc-induced U2OS cells 2.98
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.97
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.96
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.94
RNA-seq melanoma 2.92
Co-regulation of splicing by Rbfox1 and hnRNP M 2.91
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 2.91
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.91
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 2.9
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 2.9
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 2.9
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 2.9
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.89
Fusion discovery in breast cancer cell line 2.87
Evaluating pre-clinical models for studying NASH driven HCC. 2.86
DART-seq: an antibody-free method for global m6A detection 2.84
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 2.84
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.83
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 2.82
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 2.81
MYCL and EP400 are required for Max and MCPyV mediated gene activation 2.8
mRNA expression profile of Lymphocytes by high-throuput sequencing 2.79
Loss of CREBBP results in gene expression repression in lymphoma cells 2.78
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.78
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.77
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.75
Gene expression analysis upon mtDNA depletion 2.74
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.74
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 2.73
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.72
Global Mapping of Human RNA-RNA Interactions 2.71
Transcriptomic analyssis following EHMT1/2 inhibition 2.71
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 2.71
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.7
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 2.69
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.68
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 2.68
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 2.66
RNA-sequencing of human tendon after injury 2.65
Pharmacologic inhibition of STAT5 in AML 2.65
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 2.62
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 2.6
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.59
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.58
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 2.58
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 2.57
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 2.53
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 2.51
LncRNA-GAS5 negative regulation of YAP-target genes expression 2.51
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 2.5
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 2.49
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.45
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.45
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 2.45
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.41
RNA transcriptome analysis during HSV-1 infection 2.39
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.35
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 2.33
Comparative Analysis of Cas9 Activators Across Multiple Species 2.31
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.28
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.28
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.28
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 2.26
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 2.25
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.24
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 2.22
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 2.22
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 2.2
Characterization of human ILC2 subsets 2.2
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.16
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 2.13
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.13
Efficient derivation of microglia-like cells from human pluripotent stem cells 2.12
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.11
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.11
Clinker: visualizing fusion genes detected in RNA-seq data 2.11
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 2.11
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 2.11
Downregulation of DDX5/DDX17 and REST 2.1
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 2.1
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 2.1
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.08
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 2.08
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 2.08
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 2.04
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.02
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 2.01
Effect of FGF13 depletion on the H460 cell line 2.01
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 2.0
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 2.0
Illumina Total RNA-seq in HeLa 1.98
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.97
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 1.94
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 1.92
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 1.9
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.9
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.9
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 1.87
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 1.87
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.87
FGF2 regulation of gene expression in stable inducible Neurons 1.85
PTHrP overexpression in MCF7 cells 1.84
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.82
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.82
Controlling for gene expression changes in transcription factor protein networks. 1.81
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 1.8
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.79
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 1.79
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.79
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.78
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 1.74
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.74
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.73
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.7
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.7
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.67
Downregulation of LATS kinases alters p53 to promote cell migration 1.67
Identification of long noncoding RNAs regulated by p53 1.66
The Glioma-Infiltrating T Cell Receptor Repertoire 1.64
FOXP2's impact on the primate transcriptome 1.59
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 1.58
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.57
Energy Metabolism during Anchorage-Independence 1.55
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 1.5
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 1.48
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 1.47
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.47
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.47
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.45
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 1.45
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.44
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.44
Functional significance of the HIV-1 Tat signature amino acid residues 1.43
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.42
Global epigenomic reconfiguration during mammalian brain development 1.42
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 1.42
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.37
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.36
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.36
naive T cell heterogeneity after neonatal thymectomy 1.31
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 1.3
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 1.3
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.3
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.3
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.28
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.27
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 1.24
Discovering human diabetes-risk gene function with genetics and physiological assays 1.23
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 1.2
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 1.2
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.19
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 1.19
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.15
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.12
BASP1 modifies the Tamoxifen response 1.1
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.07
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.07
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.04
The circadian transcriptional landscape in primary human mammary epithelial cells 1.02
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 1.02
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.02
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.02
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.01
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.01
Macrophage Ad5f35 M2 Challenge 1.0
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.97
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.97
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.97
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.95
Human optic chiasm from healthy controls and multiple sclerosis patients 0.95
Multiple sclerosis and EAE 0.95
An optimization system for isolating and sequencing of single human colon cancer cells 0.95
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 0.94
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.94
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.93
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.92
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.92
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.91
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.89
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.88
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.88
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.86
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 0.85
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.85
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.81
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.81
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.81
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.81
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.8
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.8
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.8
MCF-7 as a model for functional analysis of breast cancer risk variants 0.79
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.76
Gene expression analysis of human hepatocellular cancers 0.75
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 0.74
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.73
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.73
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.73
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.71
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.7
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.7
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.69
Function and hormonal regulation of GATA3 in human first trimester placentation 0.67
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.65
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.64
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 0.63
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.6
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.6
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.59
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.58
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.58
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.55
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.54
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.49
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.45
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.45
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.45
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.43
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.43
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.43
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.4
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.37
Epigenomic conservation of transposable element silencing 0.35
Epigenomic conservation of transposable element silencing [RNA-seq] 0.35
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.34
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.34
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.32
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.32
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 0.31
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 0.29
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.29
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.29
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.28
Transcriptome of EBV-infected gastric cancer cell lines 0.27
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.27
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.26
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.25
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.25
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.24
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.23
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.23
STX4 Over-Expression in Human islets 0.22
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.21
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.21
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.2
The transcriptome and chromatin accessbility landscape of mammalian germline 0.19
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.17
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.16
Hepatic transcriptome of pediatric hepatoblastoma. 0.15
CD73 knockdown effect in pancreatic cancer cell lines 0.15
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.12
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.1
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.1
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.09
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.08
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.08
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.08
RNA-Seq from human ILC transitional populations 0.08
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.07
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 0.06
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 0.06
Human islets of varying quality: the good, the (not so) bad and the ugly 0.06
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.06
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.02
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.02
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation